Philip H. Gutin

Tumor mutational load predicts survival after immunotherapy across multiple cancer types

Robert Samstein, Chung‐Han Lee, Alexander N. Shoushtari et al. · Nature Genetics · 2019 · 4.2K citations · Full text

Cancer Immunosurveillance, Tumor Heterogeneity, Medicine +9

Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells

Florian Klemm, Roeltje R. Maas, Robert L. Bowman et al. · Cell · 2020 · 944 citations · Full text

Neuro-oncology, Immune Cells, Cancer Immunosurveillance +11

Genomic Analysis of Non- <i>NF2</i> Meningiomas Reveals Mutations in <i>TRAF7</i> , <i>KLF4</i> , <i>AKT1</i> , and <i>SMO</i>

Victoria Clark, E. Zeynep Erson‐Omay, Akdes Serin et al. · Science · 2013 · 850 citations · Full text

NovoTTF-100A versus physician’s choice chemotherapy in recurrent glioblastoma: A randomised phase III trial of a novel treatment modality

Roger Stupp, Eric T. Wong, Andrew A. Kanner et al. · European Journal of Cancer · 2012 · 828 citations

Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies

Robert L. Bowman, Florian Klemm, Leila Akkari et al. · Cell Reports · 2016 · 602 citations · Full text